Mylan Executive Chairman Robert J. Coury commented, "We note that there has been some media...
Applied Genetic Technologies Corporation and 4D Molecular Therapeutics, leaders in next-...
NeoStem, Inc., a biopharmaceutical company developing novel cell-based individualized medicine...
CCX872 is the company's second clinical compound which is an orally administered inhibitor of the chemokine receptor known as CCR2.
Explosions account for nearly 80 percent of today's combat-related injuries, and subsequent internal bleeding could prove fatal without quick intervention.
Immunotherapy review explores key questions on how biosimilar drug likenesses and differences will impact patient treatments.
The company alerted U.S. customers Tuesday that the vaccine can lose potency and fail to adequately protect against some strains of the flu.
More than half of the older adults in the United States are now taking a daily dose of aspirin, even though its use is not recommended by the Food and Drug Administration for most people who have not yet had a heart attack or stroke.
The nation's poultry industry may have to live with a deadly bird flu strain for several years, which would be "devastating," the U.S. Department of Agriculture's chief veterinary officer said Thursday.
A company with deep roots at the University of Wisconsin-Madison wants to make blood sampling less painful and more convenient.
Kenneth C. Frazier, chairman and CEO of Merck & Co., Inc., was elected chairman of the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA).
The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS).
Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.
PhRMA honored 13 employees from 12 biopharmaceutical companies as “We Work For Health Champions” for their extraordinary efforts in policy advocacy and community service.
A group of top doctors has demanded Columbia University remove Dr. Oz, citing his "egregious lack of integrity" for promoting what they call "quack treatments."
Medytox currently owns and operates several healthcare companies, including clinical testing laboratories, an electronic medical records provider, a laboratory information systems company and a medical billing company. CollabRx is a leading informatics company focused on the interpretation of complex molecular and genetic tests in cancer.
Sagent Pharmaceuticals, Inc., a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that its current EVP and Chief Legal Officer Michael Logerfo has been appointed President.
Stratus Pharmaceuticals marketed and distributed unapproved prescription drug products that were manufactured by Sonar Products, Inc., of Carlstadt, New Jersey.